Yann Cheli

Years Active: 2019-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Céline Pisibon, Amira Ouertani, Corine Bertolotto, Robert Ballotti, Yann Cheli
Immune Checkpoints in Cancers: From Signaling to the Clinic. Cancers 13 (18) (2021)
Yann Cheli, Meri K Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, Robert Ballotti
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. Molecular cancer 20 (1) (2021)
Meri K Tulic, Elisa Cavazza, Yann Cheli, Arnaud Jacquel, Carmelo Luci, Nathalie Cardot-Leccia, Hanene Hadhiri-Bzioueche, Patricia Abbe, Maéva Gesson, Laura Sormani, Claire Regazzetti, Guillaume Emmanuel Beranger, Cedric Lereverend, Caroline Pons, Abdallah Khemis, Robert Ballotti, Corine Bertolotto, Stéphane Rocchi, Thierry Passeron
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nature communications 10 (1) (2019)

Yann Cheli.css-eqlu8i{font-size:small;padding-left:4px;}